Recommended Topic Related To:


"The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternat"...



Information for Patients/Caregivers

The following information should be provided to patients receiving PERCOCET (oxycodone and acetaminophen) tablets by their physician, nurse, pharmacist, or caregiver:

  1. Patients should be aware that PERCOCET (oxycodone and acetaminophen) tablets contain oxycodone, which is a morphine-like substance.
  2. Patients should be instructed to keep PERCOCET (oxycodone and acetaminophen) tablets in a secure place out of the reach of children. In the case of accidental ingestions, emergency medical care should be sought immediately.
  3. When PERCOCET (oxycodone and acetaminophen) tablets are no longer needed, the unused tablets should be destroyed by flushing down the toilet.
  4. Patients should be advised not to adjust the medication dose themselves. Instead, they must consult with their prescribing physician.
  5. Patients should be advised that PERCOCET (oxycodone and acetaminophen) tablets may impair mental and/or physical ability required for the performance of potentially hazardous tasks (e.g., driving, operating heavy machinery).
  6. Patients should not combine PERCOCET (oxycodone and acetaminophen) tablets with alcohol, opioid analgesics, tranquilizers, sedatives, or other CNS depressants unless under the recommendation and guidance of a physician. When co-administered with another CNS depressant, PERCOCET (oxycodone and acetaminophen) tablets can cause dangerous additive central nervous system or respiratory depression, which can result in serious injury or death.
  7. The safe use of PERCOCET (oxycodone and acetaminophen) tablets during pregnancy has not been established; thus, women who are planning to become pregnant or are pregnant should consult with their physician before taking PERCOCET (oxycodone and acetaminophen) tablets.
  8. Nursing mothers should consult with their physicians about whether to discontinue nursing or discontinue PERCOCET (oxycodone and acetaminophen) tablets because of the potential for serious adverse reactions to nursing infants.
  9. Patients who are treated with PERCOCET (oxycodone and acetaminophen) tablets for more than a few weeks should be advised not to abruptly discontinue the medication. Patients should consult with their physician for a gradual discontinuation dose schedule to taper off the medication.
  10. Patients should be advised that PERCOCET (oxycodone and acetaminophen) tablets are a potential drug of abuse. They should protect it from theft, and it should never be given to anyone other than the individual for whom it was prescribed.

Last reviewed on RxList: 10/4/2010
This monograph has been modified to include the generic and brand name in many instances.


Percocet - User Reviews

Percocet User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Percocet sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Chronic Pain/Back Pain

Find tips and advances in treatment.